Eli Lilly Settles Prozac Users’ Privacy Charges

Eli Lilly & Co. settled charges it violated the privacy of 669 people who took its anti-depression drug Prozac by disclosing the e-mail address of each patient to the others.

The Federal Trade Commission said the drug maker agreed to implement procedures to ensure it would not repeat the inadvertent disclosure in June of the e-mail addresses of the Prozac users. The company may be subject to $11,000 in daily fines if it violates the agreement.

Lilly shares dropped 84 cents to close at $74.59 on the NYSE.